Company: CCIXW
Filing Date: 2025-12-05
Form Type: S-4/A
Source: 0001193125-25-309933
Chunk: 8

Company: Churchill Capital Corp IX/Cayman
Filing Date: 2025-12-05
Form: S-4/A
Chunk 8
---
 basis.”

Commencing on May 2, 2024, CCIX reimburses the Sponsor or an affiliate thereof in an amount equal to $30,000 per month for office space, utilities and secretarial and administrative support made available to us. Upon completion of the initial business combination or CCIX’s liquidation, CCIX will cease paying these monthly fees.

Prior to or in connection with the completion of the initial business combination, there may be payment by the Company to the Sponsor, officers or directors, or CCIX’s or their affiliates, of a finder’s fee, advisory fee, consulting fee or success fee for any services they render in order to effectuate the completion of the initial business combination, which, if made prior to the completion of the initial business combination, will be paid from (1) funds held outside the trust account or (2) Permitted Withdrawals (as defined herein).

The Sponsor, executive officers and directors, or any of their respective affiliates, are reimbursed for any out-of-pocket expenses incurred in connection with activities on CCIX’s behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. CCIX’s audit committee reviews on a quarterly basis all payments that were made to the Sponsor, officers, directors or CCIX’s or their affiliates. Any such payments prior to an initial business combination are made from funds held outside the trust account, including Permitted Withdrawals.

Subject to the terms of the Merger Agreement, there is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on CCIX’s behalf.

On December 18, 2023, CCIX and the Sponsor entered into a loan agreement, whereby the Sponsor agreed to loan CCIX an aggregate of up to $600,000 to cover expenses related to the CCIX IPO, pursuant to the IPO Promissory Note (as defined herein). This loan was non-interest bearing and payable on the earlier of December 31, 2024, or the date on which the Company consummated the CCIX IPO. As of September 30, 2025 and December 31, 2024, there

<div align='center'>3</div>

was no outstanding balance on the IPO Promissory Note. CCIX repaid the borrowings in full at the closing of the CCIX IPO and thereafter borrowings under the IPO Promissory Note are no longer available.

In addition, in order to fund working capital deficiencies or finance transaction costs in connection with an intended